Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Corbion N.V. Capital/Financing Update 2021

Dec 1, 2021

3826_iss_2021-12-01_d91d78e4-3f37-41a7-977a-9d25f3201a37.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

PRESS RELEASE

CORPORATE RELEASE

Corbion nv Piet Heinkade 127 • 1019 GM Amsterdam PO Box 349 • 1000 AH Amsterdam The Netherlands

T +31 (0)20 590 6911 [email protected] www.corbion.com

DATE 1 December 2021

Corbion successfully completes subordinated US Private Placement of € 100 million

Corbion has succesfully placed subordinated US Private Placement (USPP) Notes with 4 institutional investors. The issuance of €100 million consists of two tranches, €16 million at a fixed coupon rate of 1.77% and €84 million at a fixed coupon rate of 2.01% with maturities of 5 and 7 years, respectively.

The proceeds will be used to repay borrowings under the current € 300 million Revolving Credit Facility and for general corporate purposes.

This program will further optimise the maturity profile of Corbion's outstanding debt.

For more information, please contact:

Analysts and investors: Jeroen van Harten, Director Investor Relations +31 (0)20 590 6293, +31(0)6 21 577 086

Press:

Tanno Massar, Director Corporate Communications +31 (0)20 590 6325, +31 (0)6 11 589 121

Background information:

Corbion is the global market leader in lactic acid and its derivatives, and a leading supplier of emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients. We use our unique expertise in fermentation and other processes to deliver sustainable solutions for the preservation of food and food production, health, and our planet. For over 100 years, we have been uncompromising in our commitment to safety, quality, innovation and performance. Drawing on our deep application and product knowledge, we work side-by-side with customers to make our cutting-edge technologies work for them. Our solutions help differentiate products in markets such as food, home & personal care, animal nutrition, pharmaceuticals, medical devices, and bioplastics. In 2020, Corbion generated annual sales of € 986.5 million and had a workforce of 2,267 FTE. Corbion is listed on Euronext Amsterdam. For more information: www.corbion.com